THETIS PHARMACEUTICALS
Thetis Pharmaceuticals LLC is a biopharmaceutical company developing novel small molecule drugs to treat inflammatory diseases.
THETIS PHARMACEUTICALS
Industry:
Biotechnology Clinical Trials Medical Pharmaceutical
Founded:
2011-01-01
Address:
Ridgefield, Connecticut, United States
Country:
United States
Website Url:
http://www.thetispharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
22.87 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt WordPress Content Delivery Network Font Awesome Wordpress Plugins Nginx
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Leona M. and Harry B. Helmsley Charitable Trust
The Leona M. and Harry B. Helmsley Charitable Trust investment in Grant - Thetis Pharmaceuticals
National Institutes of Health
National Institutes of Health investment in Grant - Thetis Pharmaceuticals
National Institutes of Health
National Institutes of Health investment in Grant - Thetis Pharmaceuticals
National Institutes of Health
National Institutes of Health investment in Grant - Thetis Pharmaceuticals
River Valley Investors
River Valley Investors investment in Venture Round - Thetis Pharmaceuticals
Stonehenge Capital
Stonehenge Capital investment in Seed Round - Thetis Pharmaceuticals
Connecticut Innovations
Connecticut Innovations investment in Seed Round - Thetis Pharmaceuticals
Official Site Inspections
http://www.thetispharma.com Semrush global rank: 9.34 M Semrush visits lastest month: 170
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Thetis Pharmaceuticals"
Thetis Pharmaceuticals (Copy)
Thetis is a clinical-stage pharmaceutical company developing TP-317 as an oral therapy for inflammatory bowel disease (IBD) and solid tumor cancers. TP-317 is a first-in-class Resolvin E1 (RvE1) drug candidate that engages the LTB4 โฆSee details»
Leadership Team โ Thetis Pharmaceuticals (Copy)
Founded by ex-Pfizer R&D executives and healthcare entrepreneurs, Thetis is a biopharmaceutical company developing novel therapies for cancer and autoimmune diseases. โฆSee details»
Board of Directors โ Thetis Pharmaceuticals
Founded by ex-Pfizer R&D executives and healthcare entrepreneurs, Thetis is a biopharmaceutical company developing novel therapies for cancer and autoimmune diseases. โฆSee details»
Thetis Pharmaceuticals - Crunchbase Company Profile & Funding
Thetis Pharmaceuticals LLC is a biopharmaceutical company developing novel small molecule drugs to treat inflammatory diseases.See details»
Thetis Pharmaceuticals - LinkedIn
Thetis Pharmaceuticals | 1,013 followers on LinkedIn. Resolving disease without compromising host defense | Thetis is developing new medicines derived from a class of potent, naturally โฆSee details»
Thetis Pharma's Leadership Team - Team members and org chart
About. The leadership team at Thetis Pharma has a long history of experience in the pharmaceutical industry. They have worked as senior advisors at various companies, including โฆSee details»
Thetis Pharmaceuticals Company Profile | Management and
Thetis Pharmaceuticals Profile and History . Thetis is a biopharmaceutical company dedicated to improving the lives of patients suffering from autoimmune diseases and cancer.See details»
Thetis Pharmaceuticals - BioCT
Founded in 2011 by ex-Pfizer R&D executives and healthcare investors, Thetis Pharmaceuticals LLC is a biopharmaceutical company developing novel small molecule drugs for the treatment...See details»
TP-317 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 Contact Information Gary Mathias, CEO [email protected]. Executive Change Immunotherapy. ... a Seattle-based biomedical research organization. The Huang โฆSee details»
Thetis Pharmaceuticals LLC - Drug pipelines, Patents, Clinical trials ...
Explore Thetis Pharmaceuticals LLC with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 4 news, and 3 literature, Technology Platform:Small molecule drug, Drug:TP โฆSee details»
Thetis Pharmaceuticals - CB Insights
Thetispharma.com. Overview & Products; Financials; People; Executives 2. Board of Directors 2. Thetis Pharmaceuticals Management Team2 Team Members. Thetis Pharmaceuticals has 2 โฆSee details»
Scientific Advisors โ Thetis Pharmaceuticals
80 Plains Rd โข Essex, CT 06426 (203) 470-7772 โข [email protected] © 2022 Thetis Pharmaceuticals LLC. All rights reserved. Terms of Use.See details»
Thetis Pharmaceuticals - Craft
Thetis Pharmaceuticals is a biopharmaceutical company developing therapies for gastrointestinal diseases, including inflammatory bowel disease and non-alcoholic steatohepatitis.See details»
Thetis Pharmaceuticals - PitchBook
Thetis Pharmaceuticals General Information Description. Developer of small molecule therapies designed for the treatment of cancer and autoimmune diseases. The company's research has โฆSee details»
Contact โ Thetis Pharmaceuticals (Copy)
For media inquiries, please contact: Tracy Lessor, TLOW Communications Phone: 617-519-9827 Email: [email protected]See details»
Thetis Pharmaceuticals LLC (Thetis Pharmaceuticals LLC) - ่ฏ็ฉ็ฎก โฆ
Contact Information Gary Mathias, CEO [email protected]. ... a Seattle-based biomedical research organization. The Huang Laboratory at ISB is focused on investigating โฆSee details»
Thetis Pharmaceuticals - Overview, News & Similar companies
Www.thetispharma.com. Revenue <$5 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. Thetis Pharmaceuticals Secures $4.2 Million From the Helmsle... Apr 5, 2022. โฆSee details»
Thetis Pharmaceuticals Secures $4.2 Million from Helmsley to โฆ
RIDGEFIELD, CT AND NEW YORK, NY โ (April 4, 2022) โ Thetis Pharmaceuticals (โThetisโ), a pioneering therapeutics biotechnology company developing a first-in-class small molecule (TP โฆSee details»
News โ Thetis Pharmaceuticals (Copy)
Thetis Pharmaceuticals Secures $4.2 Million From the Helmsley Charitable Trust to Advance Its First-in-Class, Oral Resolvin E1 Therapy for Crohnโs DiseaseSee details»
TECHNOLOGY - Thetis Pharmaceuticals
Resolvins in their natural form as lipids are unstable, oily substances that are difficult to make into drugs. Our HEALER โข chemistry platform (H igh E fficiency A mino L ipid E nabled R elease) โฆSee details»